Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Natural van der Waals heterostructural single crystals with both magnetic and topological properties.

Wu J, Liu F, Sasase M, Ienaga K, Obata Y, Yukawa R, Horiba K, Kumigashira H, Okuma S, Inoshita T, Hosono H.

Sci Adv. 2019 Nov 15;5(11):eaax9989. doi: 10.1126/sciadv.aax9989. eCollection 2019 Nov.

2.

Critical behavior near the reversible-irreversible transition in periodically driven vortices under random local shear.

Maegochi S, Ienaga K, Kaneko S, Okuma S.

Sci Rep. 2019 Nov 11;9(1):16447. doi: 10.1038/s41598-019-51060-9.

3.

Vortex rectenna powered by environmental fluctuations.

Lustikova J, Shiomi Y, Yokoi N, Kabeya N, Kimura N, Ienaga K, Kaneko S, Okuma S, Takahashi S, Saitoh E.

Nat Commun. 2018 Nov 22;9(1):4922. doi: 10.1038/s41467-018-07352-1.

4.

Modulation of Electron-Phonon Coupling in One-Dimensionally Nanorippled Graphene on a Macrofacet of 6H-SiC.

Ienaga K, Iimori T, Yaji K, Miyamachi T, Nakashima S, Takahashi Y, Fukuma K, Hayashi S, Kajiwara T, Visikovskiy A, Mase K, Nakatsuji K, Tanaka S, Komori F.

Nano Lett. 2017 Jun 14;17(6):3527-3532. doi: 10.1021/acs.nanolett.7b00606. Epub 2017 May 23.

PMID:
28520435
5.

Mushroom body signaling is required for locomotor activity rhythms in Drosophila.

Mabuchi I, Shimada N, Sato S, Ienaga K, Inami S, Sakai T.

Neurosci Res. 2016 Oct;111:25-33. doi: 10.1016/j.neures.2016.04.005. Epub 2016 Apr 19.

PMID:
27106579
6.

Orbital Selectivity in Scanning Tunneling Microscopy: Distance-Dependent Tunneling Process Observed in Iron Nitride.

Takahashi Y, Miyamachi T, Ienaga K, Kawamura N, Ernst A, Komori F.

Phys Rev Lett. 2016 Feb 5;116(5):056802. doi: 10.1103/PhysRevLett.116.056802. Epub 2016 Feb 5.

PMID:
26894727
7.

Daily hydroxyl radical scavenging capacity of mammals.

Ienaga K, Hum Park C, Yokozawa T.

Drug Discov Ther. 2014 Apr;8(2):71-5. Review.

8.

Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells.

Ienaga K, Sohn M, Naiki M, Jaffa AA.

J Recept Signal Transduct Res. 2014 Jun;34(3):195-200. doi: 10.3109/10799893.2013.876039. Epub 2014 Mar 18.

PMID:
24641698
9.

Protective effect of an intrinsic antioxidant, HMH (5-hydroxy-1-methylhydantoin; NZ-419), against cellular damage of kidney tubules.

Ienaga K, Park CH, Yokozawa T.

Exp Toxicol Pathol. 2013 Jul;65(5):559-66. doi: 10.1016/j.etp.2012.05.001. Epub 2012 Jun 29.

PMID:
22749566
10.
14.

Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure.

Ienaga K, Nakamura K, Fujisawa T, Fukunaga Y, Nihei H, Narita M, Tomino Y, Sanaka T, Aoyagi K, Nakano K, Koide H.

Ren Fail. 2007;29(3):279-83.

PMID:
17497440
15.

Crossline levels in serum and erythrocyte membrane proteins from patients with diabetic nephropathy.

Aoki S, Hasegawa G, Shigeta H, Obayashi H, Fujii M, Kimura F, Moriwaki A, Nakamura N, Ienaga K, Nakamura K, Kondo M.

Diabetes Res Clin Pract. 2000 May;48(2):119-25.

PMID:
10802149
16.

The role of protein kinase C in the increased generation in isolated rat hepatocytes of the hydroxyl radical by puromycin aminonucleoside.

Aoyagi K, Shahrzad S, Kuzure Y, Koyama A, Nakamura K, Ienaga K.

Free Radic Res. 2000 Jun;32(6):487-96.

PMID:
10798714
17.

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N.

Diabetes. 1999 Oct;48(10):2090-5.

PMID:
10512378
18.

Synthesis of creatol, a hydroxyl radical adduct of creatinine and its increase by puromycin aminonucleoside in isolated rat hepatocytes.

Aoyagi K, Akiyama K, Kuzure Y, Takemura K, Nagase S, Ienaga K, Nakamura K, Koyama A, Narita M.

Free Radic Res. 1998 Sep;29(3):221-6.

PMID:
9802553
19.

Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.

Shibayama Y, Reddigari SR, Teruya M, Nakamura K, Fukunaga Y, Ienaga K, Nishikawa K, Suehiro S, Kaplan AP.

Biochem Pharmacol. 1998 Apr 15;55(8):1175-80.

PMID:
9719471
20.

Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.

Yamaguchi M, Nakamura N, Nakano K, Kitagawa Y, Shigeta H, Hasegawa G, Ienaga K, Nakamura K, Nakazawa Y, Fukui I, Obayashi H, Kondo M.

Diabet Med. 1998 Jun;15(6):458-62.

PMID:
9632118
22.

Naturally occurring 2'-O-methylpurine nucleosides with hypotensive properties.

Yamada T, Kageyama K, Joh Y, Konishi J, Ienaga K.

Cell Mol Life Sci. 1998 Feb;54(2):125-8.

PMID:
9539952
23.

Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.

Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M.

Biochem Biophys Res Commun. 1997 Jul 30;236(3):712-5.

PMID:
9245719
25.
26.

In vivo effect of hydroxyl radical scavenger on methylguanidine production from creatinine.

Yokozawa T, Fujitsuka N, Oura H, Ienaga K, Nakamura K.

Nephron. 1997;75(1):103-5. No abstract available.

PMID:
9031281
27.

Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.

Obayashi H, Nakano K, Shigeta H, Yamaguchi M, Yoshimori K, Fukui M, Fujii M, Kitagawa Y, Nakamura N, Nakamura K, Nakazawa Y, Ienaga K, Ohta M, Nishimura M, Fukui I, Kondo M.

Biochem Biophys Res Commun. 1996 Sep 4;226(1):37-41.

PMID:
8806589
28.

Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.

Ishii A, Kotani T, Nagaki Y, Shibayama Y, Toyomaki Y, Okukado N, Ienaga K, Okamoto K.

J Med Chem. 1996 Apr 26;39(9):1924-7.

PMID:
8627616
29.

Diabetic renal failure and serum accumulation of the creatinine oxidative metabolites creatol and methylguanidine.

Nakamura K, Ienaga K, Nakano K, Nakai M, Nakamura Y, Hasegawa G, Sawada M, Kondo M, Mori H, Kanatsuna T.

Nephron. 1996;73(4):520-5.

PMID:
8856245
30.

Crosslines, fluorophores in the AGE-related cross-linked proteins.

Ienaga K, Nakamura K, Hochi T, Nakazawa Y, Fukunaga Y, Kakita H, Nakano K.

Contrib Nephrol. 1995;112:42-51. Review.

PMID:
7554992
31.

Creatol and chronic renal failure.

Ienaga K, Nakamura K, Fukunaga Y, Nakano K, Kanatsuna T.

Kidney Int Suppl. 1994 Nov;47:S22-4. No abstract available.

PMID:
7869666
32.

Creatol, a creatinine metabolite, as a useful determinant of renal function.

Nakamura K, Ienaga K, Nakano K, Nakai M, Nakamura Y, Hasegawa G, Sawada M, Kondo M, Mori H, Kanatsuna T.

Nephron. 1994;66(2):140-6.

PMID:
8139732
33.

Major role of hydroxyl radical in the conversion of creatinine to creatol.

Fujitsuka N, Yokozawa T, Oura H, Nakamura K, Ienaga K.

Nephron. 1994;68(2):280-1. No abstract available.

34.

Purification of methylguanidine synthase from the rat kidney.

Yokozawa T, Fujitsuka N, Oura H, Akao T, Kobashi K, Ienaga K, Nakamura K, Hattori M.

Nephron. 1993;63(4):452-7.

PMID:
8459882
35.

L-gulono-gamma-lactone oxidase is the enzyme responsible for the production of methylguanidine in the rat liver.

Fujitsuka N, Yokozawa T, Oura H, Akao T, Kobashi K, Ienaga K, Nakamura K.

Nephron. 1993;63(4):445-51.

PMID:
8459881
36.
37.
38.

Effects of creatinine, creatol and methylguanidine on renal function.

Yokozawa T, Oura H, Ienaga K, Nakamura K.

Nihon Jinzo Gakkai Shi. 1992 Sep;34(9):973-7.

PMID:
1479734
39.

First isolation of gamma-L-glutamyl-gamma-aminobutyric acid from bovine brains.

Yamamoto A, Ienaga K, Nakamura K, Nishimura N, Higashiura K, Kurimoto Y, Inoue A, Kimurat H.

Neuroreport. 1992 Apr;3(4):330-2.

PMID:
1515591
40.

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy.

Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M.

Kidney Int. 1991 Dec;40(6):1007-12.

41.

Effects of intraamygdaloid injection of taurine and valyltaurine on amygdaloid kindled seizure in rats.

Uemura S, Ienaga K, Higashiura K, Kimura H.

Jpn J Psychiatry Neurol. 1991 Jun;45(2):383-5.

PMID:
1762226
42.

Comparison of methylguanidine production from creatinine and creatol in vivo.

Yokozawa T, Fujitsuka N, Oura H, Ienaga K, Nakamura K.

Nephron. 1991;58(1):125-6. No abstract available.

43.

Production of methylguanidine from creatinine via creatol by active oxygen species: analyses of the catabolism in vitro.

Nakamura K, Ienaga K, Yokozawa T, Fujitsuka N, Oura H.

Nephron. 1991;58(1):42-6.

PMID:
1649975
44.

Isolation of glutamyltaurine from bovine brains and proof of its gamma-linkage by the B/E linked scan SIMS technique.

Nakamura K, Higashiura K, Nishimura N, Yamamoto A, Tooyama I, Kimura H, Ienaga K.

J Neurochem. 1990 Sep;55(3):1064-6.

PMID:
2384748
45.

Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients.

Nakamura K, Ienaga K.

Experientia. 1990 May 15;46(5):470-2.

PMID:
2347396
46.

Simple method for determination of A1c-type glycated hemoglobin(s) in rats using high performance liquid chromatography.

Kondo N, Shibayama Y, Toyomaki Y, Yamamoto M, Ohara H, Nakano K, Ienaga K.

J Pharmacol Methods. 1989 May;21(3):211-21.

PMID:
2724990
47.

The metabolism of 1-methylhydantoin via 5-hydroxy-1-methylhydantoin in mammals.

Ienaga K, Nakamura K, Naka F, Goto T.

Biochim Biophys Acta. 1988 Dec 15;967(3):441-3.

PMID:
3196760
48.

Simple peptides. III. Syntheses and properties of taurine-oligopeptides containing an acidic alpha-amino acid.

Ienaga K, Nakamura K, Higashiura K, Toyomaki Y, Kimura H.

Chem Pharm Bull (Tokyo). 1988 Aug;36(8):2796-801. No abstract available.

PMID:
3240503
49.

Simple peptides. II. Syntheses and properties of taurine-dipeptides containing neutral alpha-amino acid.

Ienaga K, Higashiura K, Toyomaki Y, Matsuura H, Kimura H.

Chem Pharm Bull (Tokyo). 1988 Jan;36(1):70-7. No abstract available.

PMID:
3378309
50.

Syntheses and properties of dipeptides containing gamma-aminobutyric acid or its analogues at the C-terminal.

Ienaga K, Higashiura K, Kimura H.

Chem Pharm Bull (Tokyo). 1987 Mar;35(3):1249-54. No abstract available. Erratum in: Chem Pharm Bull (Tokyo) 1987 Jan;35(6):2622.

PMID:
3607948

Supplemental Content

Loading ...
Support Center